Circulating Insulin-Like Growth Factor 1 Levels and Migraine Risk: A Mendelian Randomization Study

ConclusionThis two-sample Mendelian randomization study showed that genetically determined increased IGF1 levels are causally associated with decreased migraine risk. Future randomized controlled trials are warranted to confirm the benefits of IGF1 administration on migraines.

http://link.springer.com/10.1007/s40120-022-00398-w

Source: Neurology and Therapy - September 1, 2022 Category: Neurology Source Type: research